Related Experiment Video

Updated: Jun 16, 2026

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection
09:25

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection

Published on: May 24, 2020

Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity

Laura Evgin1, Markus Vähä-Koskela, Julia Rintoul

  • 1Department of Biochemistry, University of Ottawa, Centre for Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, Ontario, Canada.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|February 18, 2010
PubMed

Insights

Raccoonpox virus (RCNV) shows promise as an oncolytic virus (OV) therapy. This virus effectively replicates in most cancer cells and slows tumor growth in preclinical models, offering a new avenue for cancer treatment.

Area of Science:

  • Virology
  • Oncology
  • Cancer Research

Background:

  • Oncolytic viruses (OVs) are engineered or naturally occurring viruses used in cancer therapy.
  • Raccoonpox virus (RCNV), an Orthopoxvirus, exhibits no known mammalian pathogenicity.
  • Novel OVs with natural tumor tropism are being developed for enhanced safety and efficacy.

Purpose of the Study:

  • To evaluate the oncolytic potential of Raccoonpox virus (RCNV).
  • To assess RCNV replication in cancer cell lines and its efficacy in preclinical tumor models.

Main Methods:

  • Cancer cell lines (NCI-60 panel) were screened for RCNV replication using growth curves.
  • Interferon (IFN)-alpha/beta pretreatment was used to assess normal cell response.
  • RCNV efficacy was evaluated in xenograft and syngeneic models of solid tumors, brain tumors, and lung metastasis.

Main Results:

  • RCNV demonstrated over a log increase in replication in approximately 74% of tested cancer cell lines.
  • Interferon pretreatment significantly inhibited RCNV replication in normal cell lines.
  • RCNV injection significantly slowed tumor progression and increased survival in mice across multiple tumor models, including treatment-resistant and metastatic settings.

Conclusions:

  • Raccoonpox virus (RCNV) exhibits significant oncolytic activity against a broad range of cancer cell lines.
  • RCNV demonstrates therapeutic potential in slowing tumor progression and improving survival in preclinical cancer models.
  • RCNV represents a promising candidate for oncolytic virus therapy, particularly due to its natural tumor tropism and lack of pathogenicity.

More Related Videos

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses06:13

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...